SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-040016
Filing Date
2021-03-23
Accepted
2021-03-23 07:41:02
Documents
14
Period of Report
2021-03-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2110569d1_8k.htm   iXBRL 8-K 25168
2 EXHIBIT 99.1 tm2110569d1_ex99-1.htm EX-99.1 52057
3 GRAPHIC tm21105691_ex99-1img001.jpg GRAPHIC 12679
  Complete submission text file 0001104659-21-040016.txt   281831

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lqda-20210323.xsd EX-101.SCH 3187
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20210323_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20210323_pre.xml EX-101.PRE 22711
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2110569d1_8k_htm.xml XML 3687
Mailing Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709
Business Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 21763164
SIC: 2834 Pharmaceutical Preparations